Craif Starts Offering New Product in “miSignal®️” Series, “Remote Cancer TestTM”
Craif Announces New Product in “miSignal®️” Series, “Remote Cancer TestTM” with Adding Three Additional Cancer Types (Pancreatic, Colorectal, and Esophageal) to the Lineup
Craif Launches Breast Cancer Test from “miSignal®️” Series Which Enables Early-stage Cancer Detection Using Urinary miRNA
Craif Launches Lung and Stomach Cancer Test from “miSignal®️” Series which Enables Warly-stage Cancer Detection Using Urinary miRNA
Craif Signs Term Loan Agreement with Mitsubishi UFJ Bank, Ltd. Totalling JPY 1.52 Billion
Craif and Keio University Receive Young Investigator Award for a Joint Research on Esophageal Cancer at the 60th Annual Meeting of JSCO
The Number of Medical Institution Installing miSignal®️, a Cancer Risk Screening Test, Achieves 200
Craif and Osaka University Publish Joint Study Result on Single Molecule Electron Transfer Speed of DNA/RNA in Chem
Craif and The Jikei University School of Medicine Publish Joint Study Result on Interstitial Cystitis in Translational Andrology and Urology
Craif’s Scientific Advisor & Co-Founder Yasui Introduces “Urinary MicroRNA-based Early Cancer Detection Using Nanowire-based Devices” in EUON